EMILY KURASH: Open Payments
NPI 1033777495 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,132 in 32 payments from 13 companies in 2025. Trend: 2023 $1,703 · 2024 $1,073 · 2025 $1,132
Food & beverage: $1,132
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 4 | $556 |
| Novartis Pharmaceuticals Corporation | 7 | $145 |
| Actelion Pharmaceuticals US, Inc. | 2 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Amgen Inc. | 3 | $50 |
| PFIZER INC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Boston Scientific Corporation | 1 | $25 |
Products named: SAPIEN 3 Ultra RESILIA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), LEQVIO, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, ELIQUIS, OPSUMIT, Kerendia, REPATHA.
Industry payments across AZ — which companies pay providers there.
